Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C26H33FN4O3S |
Molecular Weight | 500.629 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C3=NC(=CS3)C(=O)C4=CC=C(F)C=C4
InChI
InChIKey=UFPFGVNKHCLJJO-SSKFGXFMSA-N
InChI=1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1
Molecular Formula | C26H33FN4O3S |
Molecular Weight | 500.629 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:34:45 UTC 2023
by
admin
on
Sat Dec 16 08:34:45 UTC 2023
|
Record UNII |
6TNS415Y3P
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
582917
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
24737642
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
PRIMARY | |||
|
6TNS415Y3P
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
PRIMARY | |||
|
DB12085
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
PRIMARY | |||
|
C91079
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
PRIMARY | |||
|
DTXSID501025866
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
PRIMARY | |||
|
1005342-46-0
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
PRIMARY | |||
|
300000041394
Created by
admin on Sat Dec 16 08:34:45 UTC 2023 , Edited by admin on Sat Dec 16 08:34:45 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->MIMETIC | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR |
small molecule second mitochondrial activator of caspase (SMAC) mimetic, which both disengages IAPs from caspases and induces proteasomal degradation of cIAP-1 and -2, resulting in altered signaling through the NFκB pathway.
BINDING
|
||
|
SOLVATE->ANHYDROUS | |||
|
TARGET -> INHIBITOR |
Small molecule second mitochondrial activator of caspase (SMAC) mimetic, which both disengages IAPs from caspases and induces proteasomal degradation of cIAP-1 and -2, resulting in altered signaling through the NFκB pathway
BINDING
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |